All Things Hair Loss Pt.2 | The Gillett Health Podcast #23

About this video

In part two on hair loss, Gillett ranks common interventions by reported hair-count outcomes while warning that baseline density, clinician rating scales and selection bias make comparisons imperfect. He discusses oral and topical options for pattern loss, why oral minoxidil is argued to be more consistent than topical forms, and adjuncts he covers such as ketoconazole, caffeine, microneedling, platelet-rich plasma and neuromodulators. A major theme is safety around pregnancy and conception: Gillett strongly advises against finasteride and dutasteride exposure in that context and discusses lingering fertility effects. He closes by designing lower-systemic-exposure approaches for patients unwilling to alter systemic hormones.

Key takeaways

• Hair-count gains mean different things depending on how much hair remains at baseline
• Compare treatments on efficacy and systemic risk, not efficacy alone
• Gillett advises avoiding certain anti-androgen treatments around pregnancy and conception
• Adjuncts target inflammation, scalp health and growth stimulation through different routes
• A clinician should understand effects across organ systems, not just the scalp

Episode details: published February 6, 2023 · 7.3K views · 1:12:22 long. Summary written by Self Growth Videos from the episode itself. The hormone, metabolic and peptide concepts described are Dr. Kyle Gillett’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Gillett Health is a clinical practice that treats these conditions.

← Previous: All Things Hair Loss Pt.1 | The Gillett Health Podcast #22 · Next: Is Collagen Protein The Superior Protein? | The Gillett Health Podcast #25 →

All Dr. Kyle Gillett videos · Dr. Kyle Gillett profile · Gillett Health (official site)